Why Emerson Electric Stock Dropped Today

Emerson Electric's fiscal Q3 2025 results were mixed, with non-GAAP earnings of $1.52/share beating estimates but revenue of $4.55 billion missing expectations, causing a 7.5% stock decline. Despite a significant 570 basis point improvement in pre-tax operating profit margins to 16.1% and 72% year-over-year GAAP EPS growth to $1.03, the industrial conglomerate's shares are considered expensive at nearly 29x enterprise value to free cash flow, especially given its modest 4% Q3 sales growth and full-year guidance of approximately 3.5%.

Analysis

Emerson Electric (EMR) reported mixed fiscal Q3 2025 results, triggering a 7.5% decline in its shares. The company posted a narrow non-GAAP earnings beat at $1.52 per share versus a $1.51 estimate, but missed on revenue, delivering $4.55 billion against a $4.6 billion forecast. Operationally, performance was strong, evidenced by a significant 570 basis point expansion in pre-tax operating profit margin to 16.1% and a 72% year-over-year increase in GAAP earnings to $1.03 per share. Despite management's outlook for sustained momentum and an acceleration in Q4 sales growth to 6%, the full-year revenue growth forecast remains subdued at approximately 3.5%. The primary concern highlighted is valuation; with a projected $3.2 billion in full-year free cash flow and a roughly $92 billion enterprise value ($79 billion market cap plus $13 billion net debt), the stock trades at an enterprise value-to-free cash flow multiple of nearly 29x. This valuation appears expensive for a company expecting low single-digit top-line growth.

Key Decisions for Investors

• Investors should exercise caution due to the stock's high valuation, as an enterprise value-to-free cash flow multiple near 29x appears demanding for a company guiding to just 3.5% annual sales growth.
• Monitor whether the significant improvement in operating margins can be sustained and if it is sufficient to support the premium valuation in the face of modest revenue performance.
• The guided acceleration to 6% sales growth in Q4 is a key catalyst; a failure to achieve this could validate bearish concerns, whereas a beat may be required to ease valuation pressures.